Chunde Li

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(5):395-405

Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study.

Antonarakis ES; Piulats JM; Gross-Goupil M; Goh J; Ojamaa K; Hoimes CJ; Vaishampayan U; Berger R; Sezer A; Alanko T; de Wit R; Li C; Omlin A; Procopio G; Fukasawa S; Tabata K-I; Park SH; Feyerabend S; Drake CG; Wu H; Qiu P; Kim J; Poehlein C; de Bono JS
Article: PLOS ONE. 2016;11(1):e0145545

Improving the Prediction of Prostate Cancer Overall Survival by Supplementing Readily Available Clinical Data with Gene Expression Levels of IGFBP3 and F3 in Formalin-Fixed Paraffin Embedded Core Needle Biopsy Material.

Peng Z; Andersson K; Lindholm J; Dethlefsen O; Pramana S; Pawitan Y; Nistér M; Nilsson S; Li C
Article: SPRINGERPLUS. 2016;5(1):1861

Identification of mutations, gene expression changes and fusion transcripts by whole transcriptome RNAseq in docetaxel resistant prostate cancer cells.

Ma Y; Miao Y; Peng Z; Sandgren J; De Ståhl TD; Huss M; Lennartsson L; Liu Y; Nistér M; Nilsson S; Li C
Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2014;17(1):81-90

An expression signature at diagnosis to estimate prostate cancer patients' overall survival.

Peng Z; Skoog L; Hellborg H; Jonstam G; Wingmo I-L; Hjälm-Eriksson M; Harmenberg U; Cedermark GC; Andersson K; Ahrlund-Richter L; Pramana S; Pawitan Y; Nistér M; Nilsson S; Li C
Article: PLOS ONE. 2014;9(10):e109610

Operator dependent choice of prostate cancer biopsy has limited impact on a gene signature analysis for the highly expressed genes IGFBP3 and F3 in prostate cancer epithelial cells.

Peng Z; Andersson K; Lindholm J; Bodin I; Pramana S; Pawitan Y; Nistér M; Nilsson S; Li C
Article: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2010;29(1):162

XAF1 expression and regulatory effects of somatostatin on XAF1 in prostate cancer cells.

Xing Z; Zhou Z; Yu R; Li S; Li C; Nilsson S; Liu Z
Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2008;16(12):1521-1525

Influence of MUC1 genetic variation on prostate cancer risk and survival.

Strawbridge RJ; Nister M; Brismar K; Li C; Lindström S
Article: GROWTH HORMONE & IGF RESEARCH. 2007;17(5):392-398

GHR exon 3 polymorphism: association with type 2 diabetes mellitus and metabolic disorder.

Strawbridge RJ; Kärvestedt L; Li C; Efendic S; Ostenson CG; Gu HF; Brismar K
Article: CANCER RESEARCH. 2007;67(18):8504-8510

Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis.

Lapointe J; Li C; Giacomini CP; Salari K; Huang S; Wang P; Ferrari M; Hernandez-Boussard T; Brooks JD; Pollack JR
Article: MODERN PATHOLOGY. 2007;20(4):467-473

A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis.

Lapointe J; Kim YH; Miller MA; Li C; Kaygusuz G; van de Rijn M; Huntsman DG; Brooks JD; Pollack JR
Article: CANCER RESEARCH. 2005;65(18):8118-8124

The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer.

Kim H; Lapointe J; Kaygusuz G; Ong DE; Li C; van de Rijn M; Brooks JD; Pollack JR
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2004;101(3):811-816

Gene expression profiling identifies clinically relevant subtypes of prostate cancer.

Lapointe J; Li C; Higgins JP; van de Rijn M; Bair E; Montgomery K; Ferrari M; Egevad L; Rayford W; Bergerheim U; Ekman P; DeMarzo AM; Tibshirani R; Botstein D; Brown PO; Brooks JD; Pollack JR
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2003;22(5):1003-1007

Mutation analysis of the BRG1 gene in prostate cancer clinical samples.

Valdman A; Nordenskjöld A; Fang X; Naito A; Al-Shukri S; Larsson C; Ekman P; Li C
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2003;11(4):529-533

Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen receptor gene.

Li C; Grönberg H; Matsuyama H; Weber G; Nordenskjöld M; Naito K; Bergh A; Bergerheim U; Damber J-E; Larsson C; Ekman P
Article: ONCOGENE. 2000;19(11):1392-1399

Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma.

Alimov A; Kost-Alimova M; Liu J; Li C; Bergerheim U; Imreh S; Klein G; Zabarovsky ER
Article: EUROPEAN UROLOGY. 2000;37(3):358-365

Chromosomal numerical aberrations detected by fluorescence in situ hybridization on bladder washings from patients with bladder cancer.

Marano A; Pan Y; Li C; Pagliarulo A; Elmberger G; Tribukait B; Ekman P; Bergerheim U
Article: ANTICANCER RESEARCH. 1999;19(5B):3841-3846

Somatic mutation and homozygous deletion of PTEN/MMAC1 gene of 10q23 in renal cell carcinoma.

Alimov A; Li C; Gizatullin R; Fredriksson V; Sundelin B; Klein G; Zabarovsky E; Bergerheim U
Article: PROSTATE. 1999;39(4):262-268

Links between genetic and environmental factors and prostate cancer risk.

Ekman P; Grönberg H; Matsuyama H; Kivineva M; Bergerheim US; Li C
Article: GENES CHROMOSOMES & CANCER. 1999;24(3):175-182

Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer.

Li C; Berx G; Larsson C; Auer G; Aspenblad U; Pan Y; Sundelin B; Ekman P; Nordenskjöld M; van Roy F; Bergerheim US
Article: PROSTATE. 1998;36(1):31-38

Chromosome 16q24 deletion and decreased E-cadherin expression: possible association with metastatic potential in prostate cancer.

Pan Y; Matsuyama H; Wang N; Yoshihiro S; Häggarth L; Li C; Tribukait B; Ekman P; Bergerheim US
Article: ONCOGENE. 1998;16(4):481-487

Identification of two distinct deleted regions on chromosome 13 in prostate cancer.

Li C; Larsson C; Futreal A; Lancaster J; Phelan C; Aspenblad U; Sundelin B; Liu Y; Ekman P; Auer G; Bergerheim US
Article: HUMAN MUTATION. 1998;Suppl 1:S31-S33

Germline mutations detected in the von Hippel-Lindau disease tumor suppressor gene by Southern blot and direct genomic DNA sequencing.

Li C; Weber G; Ekman P; Lagercrantz J; Norlen BJ; Akerström G; Nordenskjöld M; Bergerheim US
Article: CANCER GENETICS. 1996;86(2):95-101

Genotypic and phenotypic characterization of two newly established renal cell carcinoma cell lines.

Bergerheim US; Söderhäll M; Zabarovsky E; Franzén B; Manneborg-Sandlund A; Li C; Jacobson SH; Auer G; Klein G; Collins VP
Article: CYTOGENETIC AND GENOME RESEARCH. 1996;75(1):17-21

Chromosome imbalances in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridization.

Bentz M; Bergerheim US; Li C; Joos S; Werner CA; Baudis M; Gnarra J; Merino MJ; Zbar B; Linehan WM; Lichter P
Visa fler

Alla övriga publikationer

Corrigendum: SPRINGERPLUS. 2016;5(1):2084

Erratum to: Identification of mutations, gene expression changes and fusion transcripts by whole transcriptome RNAseq in docetaxel resistant prostate cancer cells.

Ma Y; Miao Y; Peng Z; Sandgren J; De Ståhl TD; Huss M; Lennartsson L; Liu Y; Nistér M; Nilsson S; Li C
Published paper: BRITISH JOURNAL OF UROLOGY. 1997;79 Suppl 2:35-41

Environmental and genetic factors: a possible link with prostate cancer.

Ekman P; Pan Y; Li C; Dich J

Anställningar

Anknuten till Forskning, Klinisk forskning och utbildning, Södersjukhuset, Karolinska Institutet, 2024-2027
Anknuten till Forskning, Klinisk forskning och utbildning, Södersjukhuset, Karolinska Institutet, 2024-2027

Examina och utbildning

Docent, experimentell onkologi, Karolinska Institutet, 2015
MEDICINE DOKTORSEXAMEN, INST F KIRURGISK VETENSKAP (K3), Karolinska Institutet, 1999

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI